 6. Chemotherapy other than that included in this study taxanecyclophosphamide-based regimen, e.g., TAC or TC or neoadjuvant chemotherapy; or known immunosuppressive agents including chronic oral corticosteroid use, or radiation therapy within 4 weeks of first dose of HSP-130, prior bone marrow or stem cell transplantation, or malignancy within 5 years 